X

Today's Newsletter

Submitted by admin on Mon, 01/11/2021 - 11:16

source list reference

#7d60d9
#2694a4
#32a887
#85eb24
#352625
#4d4537
#d2093c
#8e3f1c
#76b6c3
#bfcfc8
#c61417
#67e25b
#efef71
#03cffc
#42fc9a
#cc529a
#c59445
#c8cc0c
#bf6be3
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
#a153ac
#e7f6e3
#6fc969
#9a8c2c
#a9c507
#2b9ab3
#e61923
#990677
#4a7bab
#89f67c
#49a21d
#2c990a
#d7da81
#575662
#a60538
#49cde9
#c20fce
#d95d39

Today's Newsletter

Today's Newsletter

Submitted by adenham on Fri, 05/14/2021 - 13:24

Today's Newsletter

05-19-2021

Quickly catch up on the top oncology news stories of the day.

`
Addition of Celecoxib to Standard Adjuvant Therapy in Stage III Colon Cancer

The phase III CALGB/SWOG 80702 trial has shown no DFS benefit with the addition of the cyclooxygenase 2 inhibitor celecoxib to standard adjuvant therapy in patients with stage III colon cancer.

The ASCO Post
05/13/2021
``
``
Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL Cells

Using originally designed BTK PROTAC compounds, study investigators show efficient BTK degradation in chronic lymphocytic leukemia cells.

Frontiers in Oncology
05/13/2021
Esophageal Cancer: Preop Chemoradiotherapy Benefit for 10 Years

Among patients with locally advanced resectable esophageal or junctional cancer, the overall survival benefit conferred by preoperative chemoradiotherapy persists for at least 10 years.

Medscape
05/13/2021
Advancing Cancer Care in the Black Community

African Americans face a higher burden from cancer compared to other racial/ethnic groups in the U.S., and an even greater obstacle to cancer prevention, detection, treatment, and survival.

Oncology Times - Latest Articles
04/20/2021
Study Finds Ixabepilone Plus Bevacizumab Active in Platinum-Resistant or Recurrent Ovarian Cancer

The addition of bevacizumab to ixabepilone could be a promising treatment strategy for a group of patients with cancer currently lacking therapeutic options, according to data presented during the

The ASCO Post
05/12/2021
Research Progress of circRNAs in Head and Neck Cancers

In this study, the generation, characteristics, and functions of circRNAs, along with their regulatory mechanisms in head and neck cancers are summarized.

Frontiers in Oncology
04/29/2021